http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-047339-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
filingDate 2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-047339-A1
titleOfInvention DERIVATIVES OF DIFENILAZETIDONA. OBTAINING PROCESS.
abstract A compound of the formula (1) wherein: R 1 is H, C 1-6 alkyl, C 3-6 cycloalkyl or aryl; wherein said C1-6 alkyl may be optionally substituted with one or more of hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6 alkoxy, N- (C1-6 alkyl) amino, N, N- (C1-6 alkyl ) 2amino, C1-6 alkylcarbonylamino, C1-6-S (O) alkyl a, wherein a is 0-2, C3-6 cycloalkyl or aryl; and wherein any aryl group may be optionally substituted with one or two substituents selected from halo, hydroxy, C1-6 alkyl or C1-6 alkoxy; R2 and R5 are independently H, a branched or unbranched C1-6 alkyl, C3-6 cycloalkyl or aryl; wherein said C1-6 alkyl may be optionally substituted with one or more of hydroxy, amino, guanidino, cyano, carbamoyl, carboxy, C1-6 alkoxy, aryl C1-6 alkoxy, (C1-4) 3Si, N- (alkyl C1-6) amino, N, N- (C1-6 alkyl) 2amino, C1-6S alkyl (O) a, C3-6 cycloalkyl, aryl or aryl C1-6S alkyl (O) a, where a is 0- 2; and wherein any aryl group may be optionally substituted with one or two substituents selected from halo, hydroxy, C1-6 alkyl or C1-6 alkoxy; R3 is H, alkyl, halo, C1-6 alkoxy or C1-6S- alkyl; R4 is H, halo or C1-6 alkoxy; R6 is H, C1-6 alkyl, or aryl C1-6 alkyl; wherein R5 and R2 can form a ring with 2 to 7 C atoms, and where R6 and R2 can form a ring with 3 to 6 C atoms; or a pharmaceutically acceptable salt, solvate, solvate of said salt or a prodrug thereof.
priorityDate 2003-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 19.